Skip to content
Home/Companies/MedTech/Novair
Novair

Novair

MedTech·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Novair?

Novair is a French MedTech company, currently owned by Eurazeo since 2021.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Eurazeo
Investor
Eurazeo
Nov Sante Actions Non Cotees · 2020 · Healthcare

Key facts

HQFrance
SectorMedTech
Websitewww.novair.fr

More from Nov Sante Actions Non Cotees

Other portfolio companies in the same fund.

Proteor
Proteor
Active
MedTechFrance· 2025
Imapole
Imapole
Active
MedTechFrance· 2023
Kinvent
Kinvent
Active
MedTechFrance· 2023
Horus Pharma
Horus Pharma
Active
PharmaFrance· 2022
Oncodesign
Oncodesign
Active
BiotechFrance· 2022
Groupe PSIH
Groupe PSIH
Active
HealthTechFrance· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Novair?

Novair is currently owned by Eurazeo, through Nov Sante Actions Non Cotees, since 2021.

When did Eurazeo acquire Novair?

Eurazeo acquired Novair in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue